Dianthus Therapeutics Inc. (DNTH)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.17B
Last updated: Nov 17, 2026 at 11:03 AM ET
Dianthus Therapeutics Inc. (DNTH) Earnings: Report Dates and Results
Dianthus Therapeutics (DNTH) is expected to report earnings on Mar 8, 2027. In the quarter ended Sep 30, 2026, Dianthus Therapeutics reported EPS of -$0.81, above the -$0.95 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
DNTH has an expected report date of Mar 8, 2027.
Earnings History
Of the 34 quarters below that had an estimate, DNTH beat 19 and missed 15. The widest gap in the table came in the quarter ended Sep 30, 2023, when EPS landed 575.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.81 | -$0.95 | -$1.13 - -$0.39 | +14.74% | Beat | N/A | 10 | 2 up, 1 down | Nov 4, 2026 | $1.21M |
| Jun 30, 2026 | -$0.90 | -$0.93 | -$1.23 - -$0.72 | +3.23% | Beat | N/A | 8 | 1 up, 0 down | Aug 4, 2026 | $761000 |
| Mar 31, 2026 | -$0.85 | -$1.10 | -$1.56 - -$0.63 | +22.73% | Beat | N/A | 7 | N/A | May 5, 2026 | N/A |
| Dec 31, 2025 | -$1.43 | -$1.03 | -$2.01 - -$0.72 | -38.65% | Miss | N/A | 7 | 1 up, 0 down | Mar 9, 2026 | $873000 |
| Sep 30, 2025 | -$0.97 | -$0.86 | -$1.03 - -$0.76 | -12.79% | Miss | N/A | 7 | 0 up, 1 down | Nov 5, 2025 | N/A |
| Jun 30, 2025 | -$0.88 | -$0.86 | -$0.93 - -$0.81 | -2.33% | Miss | N/A | 3 | 0 up, 1 down | Aug 7, 2025 | N/A |
| Mar 31, 2025 | -$0.82 | -$0.71 | -$0.71 - -$0.71 | -15.49% | Miss | N/A | 1 | 0 up, 0 down | May 12, 2025 | $1.16M |
| Dec 31, 2024 | -$0.81 | -$0.76 | -$0.76 - -$0.76 | -6.58% | Miss | N/A | 1 | 0 up, 0 down | Mar 11, 2025 | $1.33M |
| Sep 30, 2024 | -$0.74 | -$0.60 | -$0.73 - -$0.50 | -23.33% | Miss | N/A | 9 | 0 up, 0 down | Nov 7, 2024 | $2.17M |
| Jun 30, 2024 | -$0.51 | -$0.55 | -$0.85 - -$0.28 | +7.27% | Beat | N/A | 9 | 0 up, 0 down | Aug 8, 2024 | $1.86M |
| Mar 31, 2024 | -$0.54 | -$0.44 | N/A | -22.73% | Miss | N/A | 3 | 0 up, 0 down | May 9, 2024 | $874000 |
| Dec 31, 2023 | -$0.71 | -$1.01 | -$1.05 - -$0.64 | +29.70% | Beat | N/A | 3 | 0 up, 0 down | Mar 21, 2024 | $457000 |
| Sep 30, 2023 | -$3.78 | -$0.56 | N/A | -575.00% | Miss | N/A | 1 | 0 up, 0 down | Nov 9, 2023 | $924000 |
| Jun 30, 2023 | -$0.87 | -$3.04 | N/A | +71.50% | Beat | N/A | N/A | N/A | Aug 3, 2023 | $969000 |
| Mar 31, 2023 | -$0.47 | -$0.40 | N/A | -17.50% | Miss | N/A | N/A | N/A | May 11, 2023 | $476000 |
| Dec 31, 2022 | -$0.30 | -$0.28 | N/A | -8.62% | Miss | N/A | N/A | N/A | Mar 29, 2023 | $5.24M |
| Sep 30, 2022 | -$0.27 | -$0.29 | N/A | +6.90% | Beat | N/A | N/A | N/A | Nov 3, 2022 | $1.17M |
| Jun 30, 2022 | -$0.29 | -$0.34 | N/A | +14.71% | Beat | N/A | N/A | N/A | Aug 4, 2022 | N/A |
| Mar 31, 2022 | -$0.39 | -$0.32 | N/A | -22.60% | Miss | N/A | N/A | N/A | May 16, 2022 | N/A |
| Dec 31, 2021 | -$0.33 | -$0.32 | N/A | -4.13% | Miss | N/A | N/A | N/A | Mar 8, 2022 | N/A |
| Sep 30, 2021 | -$0.30 | -$0.33 | N/A | +8.68% | Beat | N/A | N/A | N/A | Nov 4, 2021 | N/A |
| Jun 30, 2021 | -$0.32 | -$0.37 | N/A | +14.09% | Beat | N/A | N/A | N/A | Aug 5, 2021 | N/A |
| Mar 31, 2021 | -$0.36 | -$0.39 | N/A | +7.22% | Beat | N/A | N/A | N/A | May 6, 2021 | N/A |
| Dec 31, 2020 | -$0.38 | -$0.39 | N/A | +2.06% | Beat | N/A | N/A | N/A | Mar 3, 2021 | N/A |
| Sep 30, 2020 | -$0.37 | -$0.43 | N/A | +13.95% | Beat | N/A | N/A | N/A | Nov 5, 2020 | N/A |
| Jun 30, 2020 | -$0.48 | -$0.54 | N/A | +11.11% | Beat | N/A | N/A | N/A | Aug 6, 2020 | N/A |
| Mar 31, 2020 | -$0.51 | -$0.60 | N/A | +15.00% | Beat | N/A | N/A | N/A | May 7, 2020 | N/A |
| Dec 31, 2019 | -$0.59 | -$0.58 | N/A | -1.72% | Miss | N/A | N/A | N/A | Mar 3, 2020 | N/A |
| Sep 30, 2019 | -$0.54 | -$0.53 | N/A | -1.89% | Miss | N/A | N/A | N/A | Nov 13, 2019 | N/A |
| Jun 30, 2019 | -$0.48 | -$0.49 | N/A | +2.04% | Beat | N/A | N/A | N/A | Aug 8, 2019 | N/A |
| Mar 31, 2019 | -$0.44 | -$0.55 | N/A | +20.00% | Beat | N/A | N/A | N/A | May 9, 2019 | N/A |
| Dec 31, 2018 | -$0.50 | -$0.53 | N/A | +5.66% | Beat | N/A | N/A | N/A | Mar 19, 2019 | N/A |
| Sep 30, 2018 | -$0.49 | -$0.67 | N/A | +26.87% | Beat | N/A | N/A | N/A | Nov 8, 2018 | N/A |
| Jun 30, 2018 | -$3.13 | -$1.13 | N/A | -176.99% | Miss | N/A | N/A | N/A | Aug 9, 2018 | N/A |
| Mar 31, 2018 | -$4.45 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 30, 2018 | N/A |
| Dec 31, 2017 | -$1.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2018 | N/A |
| Mar 31, 2017 | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2017 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$4.10, after -$2.60 the year before. It was -$1.18 for the year ended Dec 31, 2017, the oldest of the 9 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$4.10 | N/A |
| Dec 31, 2024 | -$2.60 | N/A |
| Dec 31, 2023 | -$5.83 | N/A |
| Dec 31, 2022 | -$1.25 | N/A |
| Dec 31, 2021 | -$1.31 | N/A |
| Dec 31, 2020 | -$1.74 | N/A |
| Dec 31, 2019 | -$2.05 | N/A |
| Dec 31, 2018 | -$8.57 | N/A |
| Dec 31, 2017 | -$1.18 | N/A |
Frequently Asked Questions About DNTH
When is Dianthus Therapeutics's next earnings date?
Dianthus Therapeutics's next earnings report is expected for Mar 8, 2027.
Did DNTH beat earnings estimates last quarter?
Yes. Dianthus Therapeutics reported EPS of -$0.81 for the quarter ended Sep 30, 2026, above the -$0.95 estimate, a 14.74% surprise.
What EPS do analysts expect from DNTH next quarter?
The consensus EPS estimate for Dianthus Therapeutics for the quarter ending Dec 31, 2026 is -$0.98 from 17 analysts, with estimates from -$1.06 to -$0.88.
How often does DNTH beat earnings estimates?
Dianthus Therapeutics beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -4.39%.
DNTH pages: Overview, Earnings, Forecast, Financials, Competitors